Akiko Matsui

417 total citations
27 papers, 319 citations indexed

About

Akiko Matsui is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Akiko Matsui has authored 27 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Surgery. Recurrent topics in Akiko Matsui's work include Diabetes Treatment and Management (6 papers), Metabolism, Diabetes, and Cancer (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Akiko Matsui is often cited by papers focused on Diabetes Treatment and Management (6 papers), Metabolism, Diabetes, and Cancer (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Akiko Matsui collaborates with scholars based in Japan, Sweden and Germany. Akiko Matsui's co-authors include Tomonori Oura, Noriyuki Iwamoto, Yukiko Onishi, Hiroshi Suemune, Miyuki Takahashi, Kiyoshi Sakai, Masanori Imai, Kazuhisa Funakoshi, Masakazu Takeuchi and Masakazu Tanaka and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Journal of Chromatography A and Tetrahedron.

In The Last Decade

Akiko Matsui

26 papers receiving 308 citations

Peers

Akiko Matsui
Pascal Druzgala United States
Touraj Shokati United States
Dwight D. Stiff United States
William DeMaio United States
Mette Guldbrandt Denmark
Monika Pietrzak Poland
Katarzyna Kosicka Poland
Jennifer M. Malinowski United States
Omri Wolk Israel
Sylvie Fernandez France
Pascal Druzgala United States
Akiko Matsui
Citations per year, relative to Akiko Matsui Akiko Matsui (= 1×) peers Pascal Druzgala

Countries citing papers authored by Akiko Matsui

Since Specialization
Citations

This map shows the geographic impact of Akiko Matsui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akiko Matsui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akiko Matsui more than expected).

Fields of papers citing papers by Akiko Matsui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akiko Matsui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akiko Matsui. The network helps show where Akiko Matsui may publish in the future.

Co-authorship network of co-authors of Akiko Matsui

This figure shows the co-authorship network connecting the top 25 collaborators of Akiko Matsui. A scholar is included among the top collaborators of Akiko Matsui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akiko Matsui. Akiko Matsui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fukami, Tatsuki, Takashi Kudo, Masataka Nakano, et al.. (2024). Iminium ion metabolites are formed from nintedanib by human CYP3A4. Drug Metabolism and Pharmacokinetics. 57. 101025–101025.
2.
Fukami, Tatsuki, et al.. (2023). Development and Validation of a Proteomic Correlation Profiling Technique to Detect and Identify Enzymes Involved in Metabolism of Drugs of Concern. Drug Metabolism and Disposition. 51(7). 824–832. 3 indexed citations
3.
Sato, Rei, Tatsuki Fukami, Masataka Nakano, et al.. (2023). Characterization of Enzymes Involved in Nintedanib Metabolism in Humans. Drug Metabolism and Disposition. 51(6). 733–742. 2 indexed citations
4.
Ishikawa, Kensuke, Michiko Asano, Hajime Hirata, et al.. (2023). One year safety and immunogenicity of AZD1222 (ChAdOx1 nCoV-19): Final analysis of a randomized, placebo-controlled phase 1/2 trial in Japan. Vaccine. 41(29). 4199–4205. 4 indexed citations
5.
Ichida, Hiroyuki, Tatsuki Fukami, Kenji Mishiro, et al.. (2023). Identification of HSD17B12 as an enzyme catalyzing drug reduction reactions through investigation of nabumetone metabolism. Archives of Biochemistry and Biophysics. 736. 109536–109536. 3 indexed citations
6.
Ohgaki, Ryuichi, Chunhuan Jin, Minhui Xu, et al.. (2022). Functional coupling of organic anion transporter OAT10 (SLC22A13) and monocarboxylate transporter MCT1 (SLC16A1) influencing the transport function of OAT10. Journal of Pharmacological Sciences. 150(1). 41–48. 6 indexed citations
7.
Asano, Michiko, Hiroshi Okada, Y. Itoh, et al.. (2021). Immunogenicity and safety of AZD1222 (ChAdOx1 nCoV-19) against SARS-CoV-2 in Japan: a double-blind, randomized controlled phase 1/2 trial. International Journal of Infectious Diseases. 114. 165–174. 22 indexed citations
8.
Takayama, Kazuo, Kohei Ito, Akiko Matsui, et al.. (2020). In Vivo Gene Expression Profile of Human Intestinal Epithelial Cells: From the Viewpoint of Drug Metabolism and Pharmacokinetics. Drug Metabolism and Disposition. 49(3). 221–232. 19 indexed citations
9.
10.
11.
Iwamoto, Noriyuki, et al.. (2017). Subgroup Analysis Stratified by Baseline Pancreatic β-cell Function in a Japanese Study of Dulaglutide in Patients with Type 2 Diabetes. Diabetes Therapy. 9(1). 383–394. 3 indexed citations
12.
13.
14.
Inagaki, Nobuya, Eiichi Araki, Tomonori Oura, et al.. (2016). The combination of dulaglutide and biguanide reduced bodyweight in J apanese patients with type 2 diabetes. Diabetes Obesity and Metabolism. 18(12). 1279–1282. 5 indexed citations
15.
Wakata, Akihiro, Atsuko Matsuoka, Kohji Yamakage, et al.. (2006). SFTG international collaborative study on in vitro micronucleus test. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 607(1). 88–124. 21 indexed citations
16.
Tanaka, Masakazu, Miyuki Takahashi, Masanori Imai, et al.. (2001). Enantio- and diastereoselective construction of 4,9-dimethylspiro[4.4]nonane-2,7-dione using Rh-catalyzed asymmetric cyclization. Tetrahedron. 57(7). 1197–1204. 29 indexed citations
17.
Harada, Ken‐ichi, Akiko Matsui, Y. Shimizu, Ryoko Yamamoto, & Kiyonaga Fujii. (2001). Abnormal elution behavior of ornitine derivatized with 1-fluoro-2,4-dinitrophenyl-5-leucinamide in advanced Marfey’s method. Journal of Chromatography A. 921(2). 187–195. 18 indexed citations
18.
19.
Matsui, Akiko, et al.. (1995). Simultaneous determination of citalopram and its metabolites by high-performance liquid chromatography with column switching and fluorescence detection by direct plasma injection. Journal of Chromatography B Biomedical Sciences and Applications. 668(2). 299–307. 44 indexed citations
20.
Komatsu, Keiji, Akiko Matsui, & Susumu Satoh. (1986). Beneficial effect of chymostatin on dystrophic mice. Experimental Neurology. 93(1). 110–116. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pascal Druzgala Breakdown of academic impact, for papers by Touraj Shokati Breakdown of academic impact, for papers by Dwight D. Stiff Breakdown of academic impact, for papers by William DeMaio Breakdown of academic impact, for papers by Mette Guldbrandt Breakdown of academic impact, for papers by Monika Pietrzak Breakdown of academic impact, for papers by Katarzyna Kosicka Breakdown of academic impact, for papers by Jennifer M. Malinowski Breakdown of academic impact, for papers by Omri Wolk Breakdown of academic impact, for papers by Sylvie Fernandez
Rankless by CCL
2026